Spontaneous and deliberate creative cognition during and after psilocybin exposure

N. L. Mason, K. P. C. Kuypers, J. T. Reckweg, F. Müller, D. H. Y. Tse, B. Da Rios, S. W. Toennes, P. Stiers, A. Feilding & J. G. Ramaekers

Abstract

Creativity is an essential cognitive ability linked to all areas of our everyday functioning. Thus, finding a way to enhance it is of broad interest. A large number of anecdotal reports suggest that the consumption of psychedelic drugs can enhance creative thinking; however, scientific evidence is lacking. Following a double-blind, placebo-controlled, parallel-group design, we demonstrated that psilocybin (0.17 mg/kg) induced a time- and construct-related differentiation of effects on creative thinking. Acutely, psilocybin increased ratings of (spontaneous) creative insights, while decreasing (deliberate) task-based creativity. Seven days after psilocybin, number of novel ideas increased. Furthermore, we utilized an ultrahigh field multimodal brain imaging approach, and found that acute and persisting effects were predicted by within- and between-network connectivity of the default mode network. Findings add some support to historical claims that psychedelics can influence aspects of the creative process, potentially indicating them as a tool to investigate creativity and subsequent underlying neural mechanisms.

Trial NL6007; psilocybin as a tool for enhanced cognitive flexibility; https://www.trialregister.nl/trial/6007.

Full Article

More publications from the Beckley/Maastricht Psychedelic Programme

Inter-individual variability in neural response to low doses of LSD

Translational Psychiatry, 2024

Read more

Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study

Brain, Behavior, and Immunity, 2023

Read more

Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study

European Journal of Pain

Read more

Spontaneous and deliberate creative cognition during and after psilocybin exposure

Translational Psychiatry, 2021

Read more

Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study

European Neuropsychopharmacology, 2020

Read more

Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide microdoses in healthy participants

Clinical Pharmacology and Therapeutics, 2020

Read more

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers

ACS Pharmacology & Translational Science, 2020

Read more

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers

Journal of Psychopharmacology, 2020

Read more

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin

Nature – Neuropsychopharmacology, 2020

Read more